Login / Signup

Low-Molecular-Weight Heparin Is Superior to Aspirin in the Prevention of Thromboembolic Disease: Or Is It?

Javad ParviziDavid E DeMikMichael DunbarWilliam J HozackMichael A MontPaul F Lachiewicz
Published in: The Journal of bone and joint surgery. American volume (2022)
Keyphrases
  • low dose
  • venous thromboembolism
  • cardiovascular events
  • growth factor
  • antiplatelet therapy
  • atrial fibrillation
  • type diabetes
  • acute coronary syndrome
  • percutaneous coronary intervention
  • anti inflammatory drugs